MedPath

New Haven Pharmaceuticals, Inc.

New Haven Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2008-01-01
Employees
11
Market Cap
-
Website
http://www.newhavenpharma.com

Length of Effect of Extended Release Aspirin on Platelets in Patients With Diabetes and Heart Disease

Phase 1
Completed
Conditions
Cardiovascular Disease
Interventions
Drug: Aspirin
Drug: Durlazaâ„¢
First Posted Date
2015-02-25
Last Posted Date
2015-08-06
Lead Sponsor
New Haven Pharmaceuticals, Inc.
Target Recruit Count
41
Registration Number
NCT02370680
Locations
🇺🇸

Platelet and Thrombosis Research, LLC, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath